医学
操作员(生物学)
数据库
计算机科学
生物化学
化学
抑制因子
转录因子
基因
作者
Saurabh Chandan,Daryl Ramai,Daniel Mozell,Antonio Facciorusso,David L. Diehl,Gursimran Kochhar
标识
DOI:10.1016/j.gie.2024.01.043
摘要
ABSTRACT
Background and aims
SpyGlass single operator cholangioscopy (SOC) system is generally considered safe but adds additional risks to those associated with standard endoscopic retrograde cholangiopancreatography. Methods
We evaluated adverse events (AEs) with the SpyGlass System reported in the United States Food and Drug Administration (FDA) Manufacturer and User Facility Device Experience (MAUDE) database between January 2016 & August 2023. Results
A total of 2331 device problems (SpyGlass DS:1301, SpyGlass DS II:1010) were reported. An optical problem was the most reported issue with 83 for the SpyGlass DS and 457 for the SpyGlass DS II. Patient related events were found in 62 (3.5%) of 1743 reports: 33 with SpyGlass DS, and 29 with SpyGlass DSII. The most common AEs were bleeding/hemorrhage followed by perforation, infection, fever, or sepsis and pancreatitis. Conclusions
Our findings add to the existing literature and provides a fuller picture of potential problems associated with SpyGlass™ SOC.
科研通智能强力驱动
Strongly Powered by AbleSci AI